Development of HER-2/neu (HER2)-specific T Cell Immunity in Patients with HER2-positive Inflammatory Breast Cancer (IBC) May Impact Prognosis

Posters
2009
TVG Cancer Vaccines
Salazar LG, Wallace D, Mukherjee P, Higgins D, Childs J, Bates N, Coveler AL, and Disis ML.